Beijing Cancer Hostital
Beijing Cancer Hostital
Beijing, Beijing Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SI-B001 Combined With Irinotecan in the Treatment of Recurrent Metastatic Esophageal Squamous Cell Carcinoma. | Esophageal Squamous Cell Carcinomas | Active, not recruiting | Phase 2 | 2025-09-26 | NCT05022654 |